<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Saudi J Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Saudi J Anaesth</journal-id><journal-id journal-id-type="publisher-id">SJA</journal-id><journal-title-group><journal-title>Saudi Journal of Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">1658-354X</issn><issn pub-type="epub">0975-3125</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28442956</article-id><article-id pub-id-type="pmc">5389236</article-id><article-id pub-id-type="publisher-id">SJA-11-177</article-id><article-id pub-id-type="doi">10.4103/1658-354X.203027</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A comparison between intravenous lidocaine and ketamine on acute and chronic pain after open nephrectomy: A prospective, double-blind, randomized, placebo-controlled study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Jendoubi</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Naceur</surname><given-names>Imed Ben</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Bouzouita</surname><given-names>Abderrazak</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Trifa</surname><given-names>Mehdi</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghedira</surname><given-names>Salma</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Chebil</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Houissa</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anaesthesia and Intensive Care and Urology, Charles Nicolle Hospital of Tunis, Tunis, Tunisia</aff><aff id="aff2"><label>1</label>Department of Anaesthesia and Intensive Care, Children Hospital of Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Ali Jendoubi, Department of Anaesthesia and Intensive Care, Faculty of Medicine of Tunis, Charles Nicolle Hospital of Tunis, University of Tunis El Manar, Tunis, Tunisia. E-mail: <email xlink:href="jendoubi_ali@yahoo.fr">jendoubi_ali@yahoo.fr</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2017</year></pub-date><volume>11</volume><issue>2</issue><fpage>177</fpage><lpage>184</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2017 Saudi Journal of Anaesthesia</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Recently, there has been increasing interest in the use of analgesic adjuncts such as intravenous (IV) ketamine and lidocaine.</p></sec><sec id="st2"><title>Objectives:</title><p>To compare the effects of perioperative IV lidocaine and ketamine on morphine requirements, pain scores, quality of recovery, and chronic pain after open nephrectomy.</p></sec><sec id="st3"><title>Study Design:</title><p>A prospective, randomized, placebo-controlled, double-blind trial.</p></sec><sec id="st4"><title>Settings:</title><p>The study was conducted in Charles Nicolle University Hospital of Tunis.</p></sec><sec id="st5"><title>Methods:</title><p>Sixty patients were randomly allocated to receive IV lidocaine: bolus of 1.5 mg/kg at the induction of anesthesia followed by infusion of 1 mg/kg/h intraoperatively and for 24 h postoperatively or ketamine: bolus of 0.15 mg/kg followed by infusion of 0.1 mg/kg/h intraoperatively and for 24 h postoperatively or an equal volume of saline (control group [CG]).</p></sec><sec id="st6"><title>Measurements:</title><p>Morphine consumption, visual analog scale pain scores, time to the first passage of flatus and feces, postoperative nausea and vomiting (PONV), 6-min walk distance (6MWD) at discharge, and the incidence of chronic neuropathic pain using the &#x0201c;Neuropathic Pain Questionnaire&#x0201d; at 3 months.</p></sec><sec id="st7"><title>Results:</title><p>Ketamine and lidocaine reduced significantly morphine consumption (by about 33% and 42%, respectively) and pain scores compared with the CG (<italic>P</italic> &#x0003c; 0.001). Lidocaine and ketamine also significantly improved bowel function in comparison to the CG (<italic>P</italic> &#x0003c; 0.001). Ketamine failed to reduce the incidence of PONV. The 6 MWD increased significantly from a mean &#x000b1; standard deviation of 27 &#x000b1; 16.2 m in the CG to 82.3 &#x000b1; 28 m in the lidocaine group (<italic>P</italic> &#x0003c; 0.001). Lidocaine, but not ketamine, reduced significantly the development of neuropathic pain at 3 months (<italic>P</italic> &#x0003c; 0.05).</p></sec><sec id="st8"><title>Conclusion:</title><p>Ketamine and lidocaine are safe and effective adjuvants to decrease opioid consumption and control early pain. We also suggest that lidocaine infusion serves as an interesting alternative to improve the functional walking capacity and prevent chronic neuropathic pain at 3 months after open nephrectomy.</p></sec></abstract><kwd-group><kwd>Analgesia</kwd><kwd>chronic pain</kwd><kwd>ketamine</kwd><kwd>lidocaine</kwd><kwd>nephrectomy</kwd><kwd>recovery</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Nephrectomy is one of the most common surgical procedures in urologic practice. Pain after surgery remains a significant clinical problem as it impairs rehabilitation and may lead to the development of chronic pain syndromes.[<xref rid="ref1" ref-type="bibr">1</xref>] The open approach represents a major physical trauma including postoperative pain and discomfort in the convalescence period.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Adequate control of postoperative pain facilitates earlier mobilization and rehabilitation.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] In addition, effective postoperative analgesia is an important measure for the prevention of chronic surgical pain.[<xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Multimodal analgesia is an important concept to improve analgesia and reduce the incidence of opioid-related adverse events.[<xref rid="ref6" ref-type="bibr">6</xref>]</p><p>Recently, there has been increasing interest in the use of analgesic adjuncts such as N-methyl-D-aspartate (NMDA) receptor antagonists (e.g., ketamine)[<xref rid="ref7" ref-type="bibr">7</xref>] and systemic infusion of lidocaine.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>The aim of the present study was to evaluate and compare the effects of perioperative intravenous (IV) lidocaine and ketamine on postoperative morphine requirement, pain scores, quality of postoperative recovery, and chronic pain after elective open nephrectomy.</p></sec><sec sec-type="methods" id="sec1-2"><title>Methods</title><p>After approval of the Local Ethics Committee and written informed consent, 63 patients undergoing elective open nephrectomy were enrolled in this prospective, randomized, double-blind study. The trial was registered at ClinicalTrials.gov (NCT 02653651). Inclusion criteria were age &#x02265;18 years and the American Society of Anesthesiologists (ASA) physical Class I or II. Exclusion criteria were known allergy to any of the study medications, an inability to understand the use of patient-controlled analgesia (PCA), renal (serum creatinine &#x0003e;2 mg/dl) or hepatic (alanine aminotransferase or aspartate aminotransferase &#x0003e;2 times normal) dysfunction, a severe cardiovascular disorder (ejection fraction &#x0003c;30%), ASA physical status &#x02265;3, history of chronic pain, epilepsy, psychiatric disorders, chronic use of opioids or alcohol, and drug abuse.</p><sec id="sec2-1"><title>Management protocol</title><p>The day before surgery, all participants received instructions on the use of the PCA device and the visual analog scale (VAS; ranging from 0 cm = no pain to 10 cm = worst possible pain).</p><p>All patients were premedicated with hydroxyzine 1 mg/kg orally, the night before surgery and 2 h before surgery. No prophylactic antiemetic was given.</p><p>General anesthesia was induced with propofol 2&#x02013;3 mg/kg, fentanyl 3 &#x003bc;g/kg, cisatracurium 0.15 mg/kg and maintained by boluses of fentanyl 1 &#x003bc;g/kg every 30 min and inhaled sevoflurane 1 minimum alveolar concentration in 50% oxygen/air. Isotonic saline was infused at 5 ml/kg/h. Normothermia was maintained with a forced-air cover.</p><p>Patients were monitored using pulse oximetry, continuous electrocardiography, noninvasive blood pressure, end-tidal carbon dioxide (CO<sub>2</sub>) and end-tidal sevoflurane concentration. Ventilation was adjusted to maintain the end-tidal CO<sub>2</sub> level at 35&#x02013;40 mmHg.</p><p>The patients were randomly assigned to one of the three treatment groups using the sealed envelope method. A &#x0201c;blinded&#x0201d; nurse prepared the study solutions. None of the other investigators involved in patient management or data collection were aware of the group assignment. Lidocaine group (LG) received an IV lidocaine bolus of 1.5 mg/kg (0.075 ml/kg of lidocaine 2%) at the induction of anesthesia, followed by a continuous infusion of 1 mg/kg/h intraoperatively and for 24 h postoperatively. Ketamine group (KG) received an IV ketamine bolus of 0.15 mg/kg (0.075 ml/kg of solution of ketamine diluted to a concentration of 2 mg/ml in normal saline) at the induction of anesthesia, followed by infusion of 0.1 mg/kg/h intraoperatively and for 24 h postoperatively. The control group (CG) received an equal volume of normal saline 0.9%. The rate of infusion was similar for the three groups according to the patient's weight.</p><p>All patients received 1 g of IV paracetamol and 20 mg of IV nefopam 30 min before the end of the surgical procedure. After completion of the surgery, neuromuscular blockade was reversed with atropine 0.02 mg/kg and neostigmine 0.04 mg/kg, and patients were extubated when adequate spontaneous ventilation was established and were transferred to postanesthesia care unit (PACU).</p><p>In the PACU, pain was controlled by titration of IV morphine by a nurse (2 mg boluses every 5 min), if permitted according to the respiration rate (&#x0003e;10 bpm) and sedation score (score &#x0003c;1), until a VAS &#x0003c;3/10 cm had been achieved. The sedation score was as follows: 0 = no sedation; 1 = intermittent drowsiness; 2 = patient drowsy but could be aroused verbally; 3 = impossible to arouse the patient verbally). Thereafter, patients were connected to a PCA device set to deliver 1 mg morphine as an IV bolus with a 7 min lockout interval. There was no basal infusion. The PCA regimen was continued for 24 h. In the surgical ward, additional postoperative analgesia was provided in three groups by the combination of the paracetamol (Perfalgan<sup>&#x000ae;</sup>, Bristol-Myers Squibb, Rueil-Malmaison, France) (1 g every 6 h) and nefopam IV (Acupan<sup>&#x000ae;</sup>, Biocodex, Gentilly, France) (20 mg every 8 h). IV ondansetron 4 mg was given on demand if patients complained of nausea or vomiting.</p></sec><sec id="sec2-2"><title>Primary outcome measures</title><p>The primary outcome of the study was the cumulative morphine consumption over 24 h PO. Consumption of morphine was recorded respectively, in the periods of 0&#x02013;1 h (T1), 0&#x02013;6 h (T2), 0&#x02013;12 h (T3), 0&#x02013;18 h (T4), and 0&#x02013;24 h after operation (T5).</p></sec><sec id="sec2-3"><title>Secondary outcome measures</title><p>Predefined secondary outcomes were: number of patients requiring morphine titration in the PACU and dose of morphine administered; pain scores (0&#x02013;10 cm) at rest and during coughing during 48 h; occurrence of opioid-induced side effects (sedation, nausea vomiting, and itching); hallucinatory effects of ketamine or signs of systemic toxicity of lidocaine such as perioral numbness and metallic taste. The recovery of bowel function was assessed by the time to first passage of flatus and feces and oral intake of clear fluids. Functional walking capacity was measured by the 6-min walk distance (6MWD) in the fourth postoperative morning.[<xref rid="ref9" ref-type="bibr">9</xref>] For patients with length of stay &#x0003c;4 days, the 6 MWT was performed at discharge.</p><p>The duration of hospital stay was also recorded. At 3 months, patients were contacted by telephone and were questioned for chronic postoperative pain using the neuropathic pain 4 questionnaires. The Douleur Neuropathique 4 (DN4) questionnaire indicated neuropathic pain for patients with a score &#x02265;4.[<xref rid="ref10" ref-type="bibr">10</xref>]</p></sec><sec id="sec2-4"><title>Statistical analysis</title><p>Calculation of the sample size indicated that a minimum of 54 patients (18 per group) would be required to detect a 30% difference in morphine consumption between the interventional group (lidocaine or ketamine) and the CG for an &#x003b1; risk of 0.05 and a power of 80%, assuming a mean morphine consumption of 48 mg &#x000b1; 16 in the CG based on a preliminary evaluation.</p><p>Statistical analysis was performed with SPSS for Windows version 15.0 (SPSS, Chicago, IL, USA). Data are expressed as a mean (standard deviation [SD]). The Chi-square test was used to assess differences between groups for categorical variables. Between-group comparisons were performed with ANOVA for parametric values or the Kruskal&#x02013;Wallis test otherwise. <italic>P</italic> &#x0003c; 0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>A total of 63 patients were enrolled. Three patients were excluded: One patient because significant hemorrhage with hemodynamic instability (KG) and two cases (one in the CG and one in the LG) because of technical problems with the PCA device. Thus, 60 patients (<italic>n</italic> = 20 in each group) were included in the final analysis [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Trial flow chart. L: Lidocaine group, K: Ketamine group, C: Control group</p></caption><graphic xlink:href="SJA-11-177-g001"/></fig><p>The three groups were comparable with respect to age, height, body mass index, ASA physical status, and duration of surgery. Intraoperative fentanyl requirements were also comparable among groups [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and intraoperative data</p></caption><graphic xlink:href="SJA-11-177-g002"/></table-wrap><sec id="sec2-5"><title>Morphine consumption and pain scores</title><p>The mean titrated dose of IV morphine in the PACU was significantly greater in the CG (<italic>P</italic> &#x0003c; 0.001). The mean &#x000b1; SD cumulative morphine consumption for the 24 h after surgery was significantly decreased with lidocaine 27.8 &#x000b1; 5.51 mg and ketamine 32 &#x000b1; 6.99 mg compared with the CG 47.6 &#x000b1; 4.98 mg [<xref ref-type="fig" rid="F2">Figure 2</xref>]. During the first 48 h after surgery, the VAS pain scores at rest and during coughing and movement in LG and KG were significantly lower than CG [<xref ref-type="fig" rid="F2">Figure 2</xref>].</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>(a) Postoperative morphine consumption during the first 24 h after open nephrectomy.(b) Pain intensity at rest assessed using a visual analog scale. (c) Pain intensity during coughing assessed using a visual analog scale. (d) Pain intensity during movement assessed using a visual analog scale. *<italic>P</italic> &#x0003c; 0.05, control group compared with treatment groups (ketamine and lidocaine); <sup>&#x02021;</sup><italic>P</italic> &#x0003c; 0.05, lidocaine group compared with ketamine group</p></caption><graphic xlink:href="SJA-11-177-g003"/></fig></sec><sec id="sec2-6"><title>Opioid- induced side effects</title><p>Sedation scores were similar among groups, and no patient had a score more than 1. No urinary retention was noted in three groups at bladder catheter removal. Compared to CG, IV lidocaine infusion significantly reduced the incidence of postoperative nausea and vomiting (PONV) (no patients experienced PONV in LG (0/20) in comparison to 15 patients in CG (75%); <italic>P</italic> &#x0003c; 0.001), whereas, no significant difference was found between KG (13/20) and CG.</p></sec><sec id="sec2-7"><title>Recovery parameters</title><p>Mean time to the first flatus and to the first meal was significantly shorter in LG and KG than in CG. First defecation, mobilization time, and length of hospital stay were statistically shorter in LG and KG compared with CG [<italic>P</italic> &#x0003c; 0.05, <xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Postoperative recovery parameters and chronic neuropathic pain in the three groups</p></caption><graphic xlink:href="SJA-11-177-g004"/></table-wrap><p>The distance covered during 6-min walking test increased significantly from a mean &#x000b1; SD of 27 &#x000b1; 16.2 m in the CG to 82.3 &#x000b1; 28 m in the LG (<italic>P</italic> &#x0003c; 0.001). There was no significant difference between KG and CG patients in terms of the distance walked.</p><p>The improvement of recovery parameters (bowel function and walking capacity) was significantly better with lidocaine than ketamine [<italic>P</italic> &#x0003c; 0.05, <xref ref-type="table" rid="T2">Table 2</xref>].</p></sec><sec id="sec2-8"><title>Chronic neuropathic pain</title><p>Concerning chronic neuropathic pain, the DN4 score was calculated for all patients; it was positive (&#x02265;4) in 17 patients. In the CG, 9 patients had a DN4 score &#x02265;4 while in the LG, only one patient had a score of 5 (<italic>P</italic> = 0.006). Seven patients had a DN4 score &#x02265;4 in the KG [<xref ref-type="table" rid="T2">Table 2</xref>]. Lidocaine, but not ketamine, reduced significantly the development of chronic neuropathic pain after open nephrectomy.</p></sec><sec id="sec2-9"><title>Adverse and toxic effects of analgesic adjuncts</title><p>There were not notable lidocaine-related adverse effects. No patients complained of hallucinations or dysphoria.</p></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>This study demonstrated that perioperative IV infusion of lidocaine or ketamine during 24 h associated with morphine PCA improved postoperative analgesia and reduced total cumulative morphine consumption over a 24-h period in patients undergoing open nephrectomy. In addition, total PCA morphine requirement was decreased by about 33% and 42% in the ketamine and LGs, respectively, compared with the CG (<italic>P</italic> &#x0003c; 0.001).</p><p>Both ketamine and lidocaine significantly reduced mean VAS pain scores versus placebo (<italic>P</italic> &#x0003c; 0.05) at rest and during cough or movement for up to 48 h postoperatively. The VAS pain scores were significantly lower in the LG compared with the KG in the first 12 h postoperatively (<italic>P</italic> &#x0003c; 0.05).</p><p>IV lidocaine has analgesic, antihyperalgesic,[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] and anti-inflammatory effects[<xref rid="ref13" ref-type="bibr">13</xref>] mediated by a variety of mechanisms including voltage-gated sodium channel blockade, G-protein-coupled receptor signaling,[<xref rid="ref14" ref-type="bibr">14</xref>] NMDA antagonism,[<xref rid="ref15" ref-type="bibr">15</xref>] suppression of central sensitization and inhibition of visceromotor reflexes.</p><p>The anti-inflammatory effects of lidocaine[<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref>] can probably be explained by the lower neutrophil accumulation at the site of injury[<xref rid="ref18" ref-type="bibr">18</xref>] and reduced release of inflammatory mediators. These actions justify its use in a multimodal approach to postoperative analgesia.</p><p>The studies showed a reduction in 24-h opioid consumption by about 50% in outpatients undergoing laparoscopic surgery,[<xref rid="ref19" ref-type="bibr">19</xref>] cholecystectomy,[<xref rid="ref20" ref-type="bibr">20</xref>] and laparoscopic colectomy.[<xref rid="ref21" ref-type="bibr">21</xref>] Another recent study in patients who underwent laparoscopic nephrectomy, Tauzin-Fin <italic>et al</italic>.[<xref rid="ref22" ref-type="bibr">22</xref>] found that IV lidocaine reduced the overall postoperative morphine consumption by about 66% as well as pain score at rest and during coughing during the first 2 postoperative days. A more recent Cochrane review[<xref rid="ref8" ref-type="bibr">8</xref>] analyzed 45 studies (2802 patients) and showed that pain immediately after surgery and until 24 h was reduced by lidocaine infusion when compared to placebo or usual care.</p><p>Ketamine acts mainly as an NMDA receptor antagonist. It attenuates central sensitization induced by tissue injury and decreases the development of opioid tolerance.[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref>] Our study showed that a 24-h low-dose continuous IV infusion of ketamine combined with morphine PCA reduced morphine consumption by 33% compared to CG without any increase of side effects such as sedation or psychiatric disorders due to ketamine.</p><p>In a meta-analysis of studies of more than 2000 patients, the authors found that perioperative subanesthetic doses of ketamine reduced 24 h PCA morphine consumption. Adverse effects were mild or absent.[<xref rid="ref26" ref-type="bibr">26</xref>] A more recent narrative review[<xref rid="ref7" ref-type="bibr">7</xref>] concluded that ketamine was effective in controlling postoperative pain, but there is no consensus about the best ketamine administration method. Ketamine was administered using a variety of regimens, but the majority involved a preincisional loading dose of 0.15&#x02013;1.00 mg/kg, with additional intraoperative infusion. Further randomized controlled trials are to determine which subgroups benefit and the optimum dose and duration of therapy.</p><p>Our results showed that systemic lidocaine and ketamine also significantly improved postoperative bowel function and reduced the duration of hospitalization in comparison to the CG. The recovery was significantly better with lidocaine than ketamine. The mean time to the first flatus and bowel movement was significantly shortened by 23 h and duration of hospital stay was reduced by an average of 1.8 days in the lidocaine-treated patients in comparison to the KG.</p><p>Several factors may contribute to the postoperative ileus such as opioid use, sympathetic hyperactivity, and the release of inflammatory mediators.[<xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref>]</p><p>The positive effects of IV lidocaine on bowel function could be explained by three mechanisms: the opioid sparing effect, the anti-inflammatory effect, and the blockade of inhibitory sympathetic reflexes involved in postoperative ileus. Our data are in accordance with those of Kaba <italic>et al</italic>.[<xref rid="ref21" ref-type="bibr">21</xref>] and Tauzin-Fin <italic>et al</italic>.[<xref rid="ref22" ref-type="bibr">22</xref>] A recent Cochrane review[<xref rid="ref8" ref-type="bibr">8</xref>] confirms the benefits of lidocaine infusion on recovery of bowel function allowing for earlier rehabilitation and shorter duration of hospital stay.</p><p>However, the benefits of lidocaine in terms of recovery and reducing the length of hospital stay were not demonstrated in patients undergoing total hip arthroplasty or coronary artery bypass surgery.[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref>]</p><p>The anti-inflammatory effect of ketamine was documented in several studies.[<xref rid="ref32" ref-type="bibr">32</xref><xref rid="ref33" ref-type="bibr">33</xref>] The effect of ketamine on perioperative inflammatory responses has been studied in patients undergoing total hip arthroplasty,[<xref rid="ref34" ref-type="bibr">34</xref>] hysterectomy,[<xref rid="ref35" ref-type="bibr">35</xref>] thoracotomy,[<xref rid="ref36" ref-type="bibr">36</xref>] and cardiac[<xref rid="ref37" ref-type="bibr">37</xref>] and spine surgery.[<xref rid="ref38" ref-type="bibr">38</xref>] The role of ketamine as a component of perioperative recovery process remains unclear.</p><p>Functional walking capacity as measured by 6MWT distance increased significantly in lidocaine-treated patients. Similar findings were reported by the previous studies evaluating the functional walking capacity after laparoscopic prostatectomy[<xref rid="ref39" ref-type="bibr">39</xref>] and laparoscopic nephrectomy.[<xref rid="ref22" ref-type="bibr">22</xref>]</p><p>Our data showed that perioperative lidocaine infusion reduced significantly PONV. This is in agreement with the Vigneault <italic>et al</italic>. meta-analysis.[<xref rid="ref40" ref-type="bibr">40</xref>] However, the opioid sparing effect of ketamine did not lead to a subsequent reduction in the incidence of PONV. This finding disagree with a Cochrane review analyzing 37 studies (2240 patients) indicating that subanesthetic perioperative ketamine was effective in reducing the incidence of PONV.[<xref rid="ref26" ref-type="bibr">26</xref>] On the other hand, several studies confirm our data showing no significant reduction in PONV with ketamine infusion.[<xref rid="ref41" ref-type="bibr">41</xref><xref rid="ref42" ref-type="bibr">42</xref>] Furthermore, ketamine exacerbated PONV in patients at high risk of PONV undergoing lumbar spinal surgery.[<xref rid="ref43" ref-type="bibr">43</xref>]</p><p>In contrast to the LG, ketamine failed to improve the functional walking capacity. Our results are in line with a previous study in which ketamine failed to improve 6MWT on the 2<sup>nd</sup> postoperative day after open hysterectomy. Ketamine was given as a bolus 0.35 mg/kg, followed by ketamine infusion of 0.2 mg/kg/h for the first 2 h and then 0.12 mg/kg/h for 24 postoperative h.[<xref rid="ref35" ref-type="bibr">35</xref>]</p><p>Chronic postsurgical pain (CPSP) is defined as pain that persists for longer than 3 months.[<xref rid="ref44" ref-type="bibr">44</xref>] Inadequate pain management after surgery elevates the risk of postoperative complications and it is one of the major risk factors associated with CPSP, which adversely affects the quality of life and delays rehabilitation and return to usual activities.</p><p>CPSP is a largely unrecognized problem that may occur in 10%&#x02013;65% of postoperative patients depending on the type of surgery, with 2%&#x02013;10% of these patients experiencing severe CPSP. Little is known about the progress of persistent pain after nephrectomy.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref45" ref-type="bibr">45</xref>] One month after nephrectomy, pain has been reported in 58% and 78% of patients into two different studies.[<xref rid="ref46" ref-type="bibr">46</xref><xref rid="ref47" ref-type="bibr">47</xref>] The incidence of CPSP after open nephrectomy ranges from 4% to 27%.[<xref rid="ref48" ref-type="bibr">48</xref>]</p><p>Our results further indicated that chronic neuropathic pain was found to be significantly lower in the LG compared with the ketamine and CGs. More recent studies have also demonstrated the effectiveness of lidocaine infusion in decreasing chronic pain.[<xref rid="ref49" ref-type="bibr">49</xref><xref rid="ref50" ref-type="bibr">50</xref><xref rid="ref51" ref-type="bibr">51</xref>]</p><p>In agreement with our data, recent studies reported that perioperative ketamine improved early recovery but lacked the effect on chronic postoperative pain.[<xref rid="ref52" ref-type="bibr">52</xref><xref rid="ref53" ref-type="bibr">53</xref>]</p><p>In contrast, a recent meta-analysis performed in 2013 suggested the modest but statistically significant reduction in the incidence of chronic pain after surgery following treatment with ketamine. Unfortunately, most of the included studies were small which could lead to the overestimation of treatment effect.[<xref rid="ref54" ref-type="bibr">54</xref>]</p><p>Regarding adverse events, no lidocaine-related systemic toxicity signs were reported. Perioperative low-dose ketamine infusion was not associated with significant side effects, which is similar to the previous reports. Low-dose ketamine has been defined as a bolus of &#x0003c;1 mg/kg IV and an infusion rate &#x0003c;1.2 mg/kg/h.[<xref rid="ref55" ref-type="bibr">55</xref>]</p><p>Our study is one of the very few head-to-head randomized clinical trials comparing ketamine versus lidocaine.</p><p>The limitations of this study include its single-center design, which limits generalization of the findings. Another limitation concerns the absence of physical examination of the patients with persistent pain and the use of simple questionnaire to confirm neuropathic pain. The choice of DN4 was based on its simplicity.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>In summary, our findings confirmed beneficial effects of IV infusion of lidocaine or ketamine during the first 24 h postoperatively in combination with morphine PCA to reduce postoperative opioid consumption and improve postoperative recovery after elective open radical nephrectomy.</p><p>We could suggest that lidocaine infusion serves as an interesting alternative to improve the functional walking capacity and prevent chronic neuropathic pain at 3 months after open nephrectomy. However, our results do not support the use of ketamine for improving the 6MWT, the 4<sup>th</sup> postoperative day after open nephrectomy. Ketamine could not reduce the incidence of PONV and it failed also to prevent neuropathic pain. Nevertheless, further studies are needed to determine the best perioperative lidocaine and/or ketamine regimen for postoperative pain control and prevention of postoperative chronic pain syndrome after open nephrectomy.</p><sec id="sec2-10"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-11" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alper</surname><given-names>I</given-names></name><name><surname>Y&#x000fc;ksel</surname><given-names>E</given-names></name></person-group><article-title>Comparison of acute and chronic pain after open nephrectomy versus laparoscopic nephrectomy: A prospective clinical trial</article-title><source>Medicine (Baltimore)</source><year>2016</year><volume>95</volume><fpage>e3433</fpage><pub-id pub-id-type="pmid">27100439</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminsharifi</surname><given-names>A</given-names></name><name><surname>Salehipoor</surname><given-names>M</given-names></name><name><surname>Arasteh</surname><given-names>H</given-names></name></person-group><article-title>Systemic immunologic and inflammatory response after laparoscopic versus open nephrectomy: A prospective cohort trial</article-title><source>J Endourol</source><year>2012</year><volume>26</volume><fpage>1231</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22471699</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Holte</surname><given-names>K</given-names></name></person-group><article-title>Effect of postoperative analgesia on surgical outcome</article-title><source>Br J Anaesth</source><year>2001</year><volume>87</volume><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">11460814</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>GP</given-names></name></person-group><article-title>Multimodal analgesia techniques and postoperative rehabilitation</article-title><source>Anesthesiol Clin North America</source><year>2005</year><volume>23</volume><fpage>185</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">15763418</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Jensen</surname><given-names>TS</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><article-title>Persistent postsurgical pain: risk factors and prevention</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>1618</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16698416</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name></person-group><article-title>The value of &#x0201c;multimodal&#x0201d; or &#x0201c;balanced analgesia&#x0201d; in postoperative pain treatment</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><fpage>1048</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">8105724</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radvansky</surname><given-names>BM</given-names></name><name><surname>Shah</surname><given-names>K</given-names></name><name><surname>Parikh</surname><given-names>A</given-names></name><name><surname>Sifonios</surname><given-names>AN</given-names></name><name><surname>Le</surname><given-names>V</given-names></name><name><surname>Eloy</surname><given-names>JD</given-names></name></person-group><article-title>Role of ketamine in acute postoperative pain management: A narrative review</article-title><source>Biomed Res Int 2015</source><year>2015</year><comment>749837</comment></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranke</surname><given-names>P</given-names></name><name><surname>Jokinen</surname><given-names>J</given-names></name><name><surname>Pace</surname><given-names>NL</given-names></name><name><surname>Schnabel</surname><given-names>A</given-names></name><name><surname>Hollmann</surname><given-names>MW</given-names></name><name><surname>Hahnenkamp</surname><given-names>K</given-names></name><etal/></person-group><article-title>Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery</article-title><source>Cochrane Database Syst Rev</source><year>2015</year><volume>(7)</volume><fpage>CD009642</fpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><article-title>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><fpage>111</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12091180</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhassira</surname><given-names>D</given-names></name><name><surname>Attal</surname><given-names>N</given-names></name><name><surname>Alchaar</surname><given-names>H</given-names></name><name><surname>Boureau</surname><given-names>F</given-names></name><name><surname>Brochet</surname><given-names>B</given-names></name><name><surname>Bruxelle</surname><given-names>J</given-names></name><etal/></person-group><article-title>Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)</article-title><source>Pain</source><year>2005</year><volume>114</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">15733628</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppert</surname><given-names>W</given-names></name><name><surname>Zeck</surname><given-names>S</given-names></name><name><surname>Sittl</surname><given-names>R</given-names></name><name><surname>Likar</surname><given-names>R</given-names></name><name><surname>Knoll</surname><given-names>R</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name></person-group><article-title>Low-dose lidocaine suppresses experimentally induced hyperalgesia in humans</article-title><source>Anesthesiology</source><year>1998</year><volume>89</volume><fpage>1345</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">9856708</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirks</surname><given-names>J</given-names></name><name><surname>Fabricius</surname><given-names>P</given-names></name><name><surname>Petersen</surname><given-names>KL</given-names></name><name><surname>Rowbotham</surname><given-names>MC</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name></person-group><article-title>The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers</article-title><source>Anesth Analg</source><year>2000</year><volume>91</volume><fpage>967</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">11004058</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollmann</surname><given-names>MW</given-names></name><name><surname>Durieux</surname><given-names>ME</given-names></name></person-group><article-title>Local anesthetics and the inflammatory response: A new therapeutic indication?</article-title><source>Anesthesiology</source><year>2000</year><volume>93</volume><fpage>858</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">10969322</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollmann</surname><given-names>MW</given-names></name><name><surname>Herroeder</surname><given-names>S</given-names></name><name><surname>Kurz</surname><given-names>KS</given-names></name><name><surname>Hoenemann</surname><given-names>CW</given-names></name><name><surname>Struemper</surname><given-names>D</given-names></name><name><surname>Hahnenkamp</surname><given-names>K</given-names></name><etal/></person-group><article-title>Time-dependent inhibition of G protein-coupled receptor signaling by local anesthetics</article-title><source>Anesthesiology</source><year>2004</year><volume>100</volume><fpage>852</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">15087620</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>I</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><article-title>Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord <italic>in vitro</italic> by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics</article-title><source>Pain</source><year>1996</year><volume>64</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">8867247</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beloeil</surname><given-names>H</given-names></name><name><surname>Mazoit</surname><given-names>JX</given-names></name></person-group><article-title>Effect of local anesthetics on the postoperative inflammatory response</article-title><source>Ann Fr Anesth Reanim</source><year>2009</year><volume>28</volume><fpage>231</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19297121</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Mackensen</surname><given-names>GB</given-names></name><name><surname>Phillips-Bute</surname><given-names>B</given-names></name><name><surname>Grocott</surname><given-names>HP</given-names></name><name><surname>Glower</surname><given-names>DD</given-names></name><name><surname>Laskowitz</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery</article-title><source>Stroke</source><year>2009</year><volume>40</volume><fpage>880</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">19164788</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>AS</given-names></name><name><surname>Sinclair</surname><given-names>R</given-names></name><name><surname>Cassuto</surname><given-names>J</given-names></name><name><surname>Thomsen</surname><given-names>P</given-names></name></person-group><article-title>Influence of lidocaine on leukocyte function in the surgical wound</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>74</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1610012</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>GS</given-names><suffix>Jr</suffix></name><name><surname>Fitzgerald</surname><given-names>P</given-names></name><name><surname>Streicher</surname><given-names>LF</given-names></name><name><surname>Marcus</surname><given-names>RJ</given-names></name><name><surname>McCarthy</surname><given-names>RJ</given-names></name></person-group><article-title>Systemic lidocaine to improve postoperative quality of recovery after ambulatory laparoscopic surgery</article-title><source>Anesth Analg</source><year>2012</year><volume>115</volume><fpage>262</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22584558</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saadawy</surname><given-names>IM</given-names></name><name><surname>Kaki</surname><given-names>AM</given-names></name><name><surname>Abd El Latif</surname><given-names>AA</given-names></name><name><surname>Abd-Elmaksoud</surname><given-names>AM</given-names></name><name><surname>Tolba</surname><given-names>OM</given-names></name></person-group><article-title>Lidocaine vs. magnesium: Effect on analgesia after a laparoscopic cholecystectomy</article-title><source>Acta Anaesthesiol Scand</source><year>2010</year><volume>54</volume><fpage>549</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">19919581</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaba</surname><given-names>A</given-names></name><name><surname>Laurent</surname><given-names>SR</given-names></name><name><surname>Detroz</surname><given-names>BJ</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Durieux</surname><given-names>ME</given-names></name><name><surname>Lamy</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy</article-title><source>Anesthesiology</source><year>2007</year><volume>106</volume><fpage>11</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17197840</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauzin-Fin</surname><given-names>P</given-names></name><name><surname>Bernard</surname><given-names>O</given-names></name><name><surname>Sesay</surname><given-names>M</given-names></name><name><surname>Biais</surname><given-names>M</given-names></name><name><surname>Richebe</surname><given-names>P</given-names></name><name><surname>Quinart</surname><given-names>A</given-names></name><etal/></person-group><article-title>Benefits of intravenous lidocaine on post-operative pain and acute rehabilitation after laparoscopic nephrectomy</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2014</year><volume>30</volume><fpage>366</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">25190945</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stubhaug</surname><given-names>A</given-names></name><name><surname>Breivik</surname><given-names>H</given-names></name><name><surname>Eide</surname><given-names>PK</given-names></name><name><surname>Kreunen</surname><given-names>M</given-names></name><name><surname>Foss</surname><given-names>A</given-names></name></person-group><article-title>Mapping of punctuate hyperalgesia around A surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery</article-title><source>Acta Anaesthesiol Scand</source><year>1997</year><volume>41</volume><fpage>1124</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9366932</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Thompson</surname><given-names>SW</given-names></name></person-group><article-title>The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states</article-title><source>Pain</source><year>1991</year><volume>44</volume><fpage>293</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1828878</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Chong</surname><given-names>MS</given-names></name></person-group><article-title>Preemptive analgesia &#x02013; Treating postoperative pain by preventing the establishment of central sensitization</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><fpage>362</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">8346839</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>RF</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name></person-group><article-title>Peri-operative ketamine for acute post-operative pain: A quantitative and qualitative systematic review (Cochrane review)</article-title><source>Acta Anaesthesiol Scand</source><year>2005</year><volume>49</volume><fpage>1405</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">16223384</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holte</surname><given-names>K</given-names></name><name><surname>Kehlet</surname><given-names>H</given-names></name></person-group><article-title>Postoperative ileus: A preventable event</article-title><source>Br J Surg</source><year>2000</year><volume>87</volume><fpage>1480</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">11091234</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luckey</surname><given-names>A</given-names></name><name><surname>Livingston</surname><given-names>E</given-names></name><name><surname>Tach&#x000e9;</surname><given-names>Y</given-names></name></person-group><article-title>Mechanisms and treatment of postoperative ileus</article-title><source>Arch Surg</source><year>2003</year><volume>138</volume><fpage>206</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">12578422</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name></person-group><article-title>Opioid-induced bowel dysfunction: Pathophysiology and potential new therapies</article-title><source>Drugs</source><year>2003</year><volume>63</volume><fpage>649</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12656645</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>F</given-names></name><name><surname>Cherif</surname><given-names>K</given-names></name><name><surname>Gentili</surname><given-names>ME</given-names></name><name><surname>Enel</surname><given-names>D</given-names></name><name><surname>Abe</surname><given-names>E</given-names></name><name><surname>Alvarez</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty</article-title><source>Anesthesiology</source><year>2008</year><volume>109</volume><fpage>118</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">18580181</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insler</surname><given-names>SR</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>M</given-names></name><name><surname>Samonte</surname><given-names>AF</given-names></name><name><surname>Bazaral</surname><given-names>MG</given-names></name></person-group><article-title>Lidocaine and the inhibition of postoperative pain in coronary artery bypass patients</article-title><source>J Cardiothorac Vasc Anesth</source><year>1995</year><volume>9</volume><fpage>541</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8547556</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loix</surname><given-names>S</given-names></name><name><surname>De Kock</surname><given-names>M</given-names></name><name><surname>Henin</surname><given-names>P</given-names></name></person-group><article-title>The anti-inflammatory effects of ketamine: State of the art</article-title><source>Acta Anaesthesiol Belg</source><year>2011</year><volume>62</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">21612145</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>O</given-names></name><name><surname>Somogyi</surname><given-names>AA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sullivan</surname><given-names>T</given-names></name><name><surname>Shavit</surname><given-names>Y</given-names></name></person-group><article-title>Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis</article-title><source>Anesth Analg</source><year>2012</year><volume>115</volume><fpage>934</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">22826531</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>V</given-names></name><name><surname>Cymerman</surname><given-names>A</given-names></name><name><surname>Ben Ammar</surname><given-names>S</given-names></name><name><surname>Fiaud</surname><given-names>JF</given-names></name><name><surname>Rapon</surname><given-names>C</given-names></name><name><surname>Poindessous</surname><given-names>F</given-names></name><etal/></person-group><article-title>The analgesic efficiency of combined pregabalin and ketamine for total hip arthroplasty: A randomised, double-blind, controlled study</article-title><source>Anaesthesia</source><year>2014</year><volume>69</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">24320856</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grady</surname><given-names>MV</given-names></name><name><surname>Mascha</surname><given-names>E</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name></person-group><article-title>The effect of perioperative intravenous lidocaine and ketamine on recovery after abdominal hysterectomy</article-title><source>Anesth Analg</source><year>2012</year><volume>115</volume><fpage>1078</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">23011561</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendola</surname><given-names>C</given-names></name><name><surname>Cammarota</surname><given-names>G</given-names></name><name><surname>Netto</surname><given-names>R</given-names></name><name><surname>Cecci</surname><given-names>G</given-names></name><name><surname>Pisterna</surname><given-names>A</given-names></name><name><surname>Ferrante</surname><given-names>D</given-names></name><etal/></person-group><article-title>S+-ketamine for control of perioperative pain and prevention of post thoracotomy pain syndrome: A randomized, double-blind study</article-title><source>Minerva Anestesiol</source><year>2012</year><volume>78</volume><fpage>757</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">22441361</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welters</surname><given-names>ID</given-names></name><name><surname>Feurer</surname><given-names>MK</given-names></name><name><surname>Preiss</surname><given-names>V</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M</given-names></name><name><surname>Scholz</surname><given-names>S</given-names></name><name><surname>Kwapisz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><fpage>172</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21138901</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loftus</surname><given-names>RW</given-names></name><name><surname>Yeager</surname><given-names>MP</given-names></name><name><surname>Clark</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Abdu</surname><given-names>WA</given-names></name><name><surname>Sengupta</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery</article-title><source>Anesthesiology</source><year>2010</year><volume>113</volume><fpage>639</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">20693876</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauwick</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name><name><surname>Mistraletti</surname><given-names>G</given-names></name><name><surname>Carli</surname><given-names>F</given-names></name></person-group><article-title>Functional walking capacity as an outcome measure of laparoscopic prostatectomy: The effect of lidocaine infusion</article-title><source>Br J Anaesth</source><year>2009</year><volume>103</volume><fpage>213</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19443419</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigneault</surname><given-names>L</given-names></name><name><surname>Turgeon</surname><given-names>AF</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>D</given-names></name><name><surname>Lauzier</surname><given-names>F</given-names></name><name><surname>Zarychanski</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>L</given-names></name><etal/></person-group><article-title>Perioperative intravenous lidocaine infusion for postoperative pain control: A meta-analysis of randomized controlled trials</article-title><source>Can J Anaesth</source><year>2011</year><volume>58</volume><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">21061107</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>K</given-names></name><name><surname>Subramaniam</surname><given-names>B</given-names></name><name><surname>Steinbrook</surname><given-names>RA</given-names></name></person-group><article-title>Ketamine as adjuvant analgesic to opioids: A quantitative and qualitative systematic review</article-title><source>Anesth Analg</source><year>2004</year><volume>99</volume><fpage>482</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15271729</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elia</surname><given-names>N</given-names></name><name><surname>Tram&#x000e8;r</surname><given-names>MR</given-names></name></person-group><article-title>Ketamine and postoperative pain &#x02013; A quantitative systematic review of randomised trials</article-title><source>Pain</source><year>2005</year><volume>113</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15621365</pub-id></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JW</given-names></name><name><surname>Shim</surname><given-names>JK</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kwak</surname><given-names>YL</given-names></name></person-group><article-title>Effect of ketamine as an adjunct to intravenous patient-controlled analgesia, in patients at high risk of postoperative nausea and vomiting undergoing lumbar spinal surgery</article-title><source>Br J Anaesth</source><year>2013</year><volume>111</volume><fpage>630</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23744819</pub-id></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanDenKerkhof</surname><given-names>EG</given-names></name><name><surname>Peters</surname><given-names>ML</given-names></name><name><surname>Bruce</surname><given-names>J</given-names></name></person-group><article-title>Chronic pain after surgery: Time for standardization? A framework to establish core risk factor and outcome domains for epidemiological studies</article-title><source>Clin J Pain</source><year>2013</year><volume>29</volume><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23211602</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerbershagen</surname><given-names>HJ</given-names></name><name><surname>Dagtekin</surname><given-names>O</given-names></name><name><surname>Rothe</surname><given-names>T</given-names></name><name><surname>Heidenreich</surname><given-names>A</given-names></name><name><surname>Gerbershagen</surname><given-names>K</given-names></name><name><surname>Sabatowski</surname><given-names>R</given-names></name><etal/></person-group><article-title>Risk factors for acute and chronic postoperative pain in patients with benign and malignant renal disease after nephrectomy</article-title><source>Eur J Pain</source><year>2009</year><volume>13</volume><fpage>853</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">19010073</pub-id></element-citation></ref><ref id="ref46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>MH</given-names></name><name><surname>Mathisen</surname><given-names>L</given-names></name><name><surname>Oyen</surname><given-names>O</given-names></name><name><surname>Edwin</surname><given-names>B</given-names></name><name><surname>Digernes</surname><given-names>R</given-names></name><name><surname>Kvarstein</surname><given-names>G</given-names></name><etal/></person-group><article-title>Postoperative pain and convalescence in living kidney donors-laparoscopic versus open donor nephrectomy: A randomized study</article-title><source>Am J Transplant</source><year>2006</year><volume>6</volume><fpage>1438</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">16686768</pub-id></element-citation></ref><ref id="ref47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>KT</given-names></name><name><surname>Freedland</surname><given-names>SJ</given-names></name><name><surname>Hu</surname><given-names>JC</given-names></name><name><surname>Phelan</surname><given-names>MW</given-names></name><name><surname>Kristo</surname><given-names>B</given-names></name><name><surname>Gritsch</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy</article-title><source>J Urol</source><year>2003</year><volume>169</volume><fpage>2018</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">12771708</pub-id></element-citation></ref><ref id="ref48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>M</given-names></name><name><surname>Lorgelly</surname><given-names>P</given-names></name><name><surname>Serpell</surname><given-names>M</given-names></name></person-group><article-title>Chronic pain following donor nephrectomy &#x02013; A study of the incidence, nature and impact of chronic post-nephrectomy pain</article-title><source>Eur J Pain</source><year>2010</year><volume>14</volume><fpage>732</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">20064733</pub-id></element-citation></ref><ref id="ref49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grigoras</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>P</given-names></name><name><surname>Sattar</surname><given-names>F</given-names></name><name><surname>Shorten</surname><given-names>G</given-names></name></person-group><article-title>Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery</article-title><source>Clin J Pain</source><year>2012</year><volume>28</volume><fpage>567</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">22699129</pub-id></element-citation></ref><ref id="ref50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>CL</given-names></name><name><surname>Tella</surname><given-names>P</given-names></name><name><surname>Staats</surname><given-names>PS</given-names></name><name><surname>Vaslav</surname><given-names>R</given-names></name><name><surname>Kazim</surname><given-names>DA</given-names></name><name><surname>Wesselmann</surname><given-names>U</given-names></name><etal/></person-group><article-title>Analgesic effects of intravenous lidocaine and morphine on postamputation pain: A randomized double-blind, active placebo-controlled, crossover trial</article-title><source>Anesthesiology</source><year>2002</year><volume>96</volume><fpage>841</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11964590</pub-id></element-citation></ref><ref id="ref51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terkawi</surname><given-names>AS</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Durieux</surname><given-names>ME</given-names></name><name><surname>Thammishetti</surname><given-names>S</given-names></name><name><surname>Brenin</surname><given-names>D</given-names></name><name><surname>Tiouririne</surname><given-names>M</given-names></name></person-group><article-title>Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: A double-blind, placebo-controlled randomized trial</article-title><source>Pain Physician</source><year>2015</year><volume>18</volume><fpage>E139</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">25794212</pub-id></element-citation></ref><ref id="ref52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>C</given-names></name><name><surname>Armstrong-Brown</surname><given-names>A</given-names></name><name><surname>Burstal</surname><given-names>R</given-names></name></person-group><article-title>Perioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: A randomized, controlled trial</article-title><source>Anaesth Intensive Care</source><year>2004</year><volume>32</volume><fpage>330</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15264726</pub-id></element-citation></ref><ref id="ref53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dual&#x000e9;</surname><given-names>C</given-names></name><name><surname>Sibaud</surname><given-names>F</given-names></name><name><surname>Guastella</surname><given-names>V</given-names></name><name><surname>Vallet</surname><given-names>L</given-names></name><name><surname>Gimbert</surname><given-names>YA</given-names></name><name><surname>Taheri</surname><given-names>H</given-names></name><etal/></person-group><article-title>Perioperative ketamine does not prevent chronic pain after thoracotomy</article-title><source>Eur J Pain</source><year>2009</year><volume>13</volume><fpage>497</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">18783971</pub-id></element-citation></ref><ref id="ref54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaparro</surname><given-names>LE</given-names></name><name><surname>Smith</surname><given-names>SA</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Wiffen</surname><given-names>PJ</given-names></name><name><surname>Gilron</surname><given-names>I</given-names></name></person-group><article-title>Pharmacotherapy for the prevention of chronic pain after surgery in adults</article-title><source>Cochrane Database Syst Rev</source><year>2013</year><volume>(7)</volume><fpage>CD008307</fpage></element-citation></ref><ref id="ref55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>RL</given-names></name><name><surname>Sandler</surname><given-names>AN</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name></person-group><article-title>Use and efficacy of low-dose ketamine in the management of acute postoperative pain: A review of current techniques and outcomes</article-title><source>Pain</source><year>1999</year><volume>82</volume><fpage>111</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">10467917</pub-id></element-citation></ref></ref-list></back></article>